首页 | 本学科首页   官方微博 | 高级检索  
     

曲古抑菌素A对前列腺癌LNCaP细胞抑制效应的细胞信号通路研究
引用本文:孙圣坤,刘兵,李秀森,侯春梅,洪宝发,于晓妉. 曲古抑菌素A对前列腺癌LNCaP细胞抑制效应的细胞信号通路研究[J]. 中国临床药理学与治疗学, 2006, 11(9): 1013-1016
作者姓名:孙圣坤  刘兵  李秀森  侯春梅  洪宝发  于晓妉
作者单位:1. 军事医学科学院基础医学研究所,北京,100850;解放军总医院泌尿外科,北京,100853
2. 军事医学科学院基础医学研究所,北京,100850
3. 解放军总医院泌尿外科,北京,100853
摘    要:目的:研究组蛋白去乙酰化酶抑制剂曲古抑菌素A(1SA)对前列腺癌LNCaP细胞抑制作用的细胞信号机制。方法:半固体培养检测TSA对前列腺癌细胞集落形成能力的影响;Westem Blot分析细胞蛋白乙酰化水平、细胞信号通路蛋白及细胞周期相关蛋白的表达。结果:TSA能够有效杀伤前列腺癌LNCaP细胞,在较低浓度即能抑制具有集落形成能力的细胞;药物处理使细胞内蛋白乙酰化水平增高,乙酰化组蛋白H3积累,多种细胞信号通路的相关蛋白如雄激素受体、HER2、Raf-1、Akt、CDK4等呈时间依赖性和剂量依赖性被清除。结论:TSA能够同时阻断对细胞生长具有重要作用的多条细胞信号通路,从而对前列腺癌LNCaP细胞发挥抑制作用。

关 键 词:组蛋白脱乙酰基酶  前列腺癌  细胞信号通路  细胞凋亡  组蛋白去乙酰化酶抑制剂  曲古抑菌素A
文章编号:1009-2501(2006)09-1013-04
收稿时间:2006-04-03
修稿时间:2006-06-15

Targeting multiple signaling pathways in LNCaP prostate cancer cell line by trichostatin A
SUN Sheng-kun,LIU Bing,LI Xiu-shen,HOU Chun-mei,HONG Bao-fa,YU Xiao-dan. Targeting multiple signaling pathways in LNCaP prostate cancer cell line by trichostatin A[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(9): 1013-1016
Authors:SUN Sheng-kun  LIU Bing  LI Xiu-shen  HOU Chun-mei  HONG Bao-fa  YU Xiao-dan
Affiliation:Institute of Basic Medical Sciences, Academy of Military Medical Sciences, Beijing 100850, China ; Department of Urology, PIA General Hospital, Beefing 100853, China
Abstract:AIM: To investigate the molecular mechanisms underlying the antitumor effect of trichostatin A(TSA) on LNCaP prostate cancer cells.METHODS: Colony formation analysis was performed to assay the effect of TSA on LNCaP colony forming ability.Western blotting was used to analyze protein acetylation standard as well as the expression of a panel of signaling molecules after TSA exposure.RESULTS: TSA inhibited the colony forming ability of LNCaP cells at a very low concentration.TSA exposure caused elevated acetylation of total cellular proteins as well as accumulation of acetylated-H_3.In addition,signaling molecules which play key roles in prostate cancer such as AR,ErbB2,Raf-1,CDK4,and Akt were depleted by TSA in a dose and time-dependent manner.CONCLUSION: TSA exhibits significant antitumor activity against LNCaP cells by simultaneously interfering with multiple signaling pathways such as HER2/MAPK,AR,and PI-3K-AKT pathways.
Keywords:histone deacetylase   prostate cancer   signal transduction pathway    cell apoptosis   histone deacetylase inhibitors   trichostatin A
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号